Investment ThemesDetailed Quotes
Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

  • 1429.430
  • -6.911-0.48%
Close Dec 13 16:00 ET
1434.053High1416.748Low
Constituent Stocks: 10Top Rising: SGMO+7.33%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
SGMOSangamo Therapeutics
2.0500.140+7.33%7.80M16.08M1.9901.9102.1751.930427.73M418.28M208.65M204.04M+1.99%-9.29%-4.65%+127.78%+359.02%+393.86%+277.32%--3.82%LossLoss12.83%Biotechnology
APLSApellis Pharmaceuticals
33.1900.450+1.37%5.51M182.12M32.60032.74033.50031.7604.13B2.80B124.39M84.36M-0.90%-2.18%+18.28%-9.64%-17.85%-37.00%-44.55%--6.53%LossLoss5.32%Biotechnology
VRTXVertex Pharmaceuticals
463.730-0.390-0.08%1.10M508.67M462.330464.120466.714459.790119.42B119.08B257.53M256.79M+0.35%-0.94%-4.18%-2.97%-2.13%+12.92%+13.97%--0.43%Loss33.391.49%Biotechnology
BEAMBeam Therapeutics
27.930-0.130-0.46%879.04K24.40M27.81028.06028.29027.0212.31B1.92B82.81M68.63M+4.57%+2.05%+6.16%+7.26%+15.18%-1.72%+2.61%--1.28%LossLoss4.52%Biotechnology
AAgilent Technologies
139.000-1.910-1.36%1.47M204.33M140.360140.910140.465137.29039.64B39.49B285.19M284.11M-1.12%+0.75%+6.74%-1.92%+3.56%+2.31%+0.49%0.68%0.52%31.3831.382.25%Diagnostics & Research
CRBUCaribou Biosciences
1.910-0.030-1.55%1.28M2.40M1.9401.9401.9501.820172.96M155.82M90.55M81.58M-10.33%-12.79%-8.61%-7.73%+8.52%-68.64%-66.67%--1.57%LossLoss6.70%Biotechnology
CRSPCRISPR Therapeutics
43.780-1.620-3.57%3.19M139.31M45.01045.40045.34042.8603.74B3.68B85.35M83.95M-16.34%-14.44%-6.55%-11.54%-21.75%-29.48%-30.06%--3.80%LossLoss5.46%Biotechnology
NTLAIntellia Therapeutics
12.900-0.660-4.87%3.19M40.80M13.50013.56013.52012.4721.31B1.30B101.85M100.57M-12.36%-17.41%-14.68%-43.74%-46.25%-58.09%-57.69%--3.17%LossLoss7.73%Biotechnology
BLUEbluebird bio
6.340-1.260-16.58%720.97K4.81M7.5607.6007.5606.26061.64M61.35M9.72M9.68M-30.36%-21.73%-12.58%-35.57%-66.55%-90.31%-77.03%--7.45%LossLoss17.11%Biotechnology
EDITEditas Medicine
1.440-0.450-23.81%10.56M16.12M1.7501.8901.7701.410118.87M111.34M82.55M77.32M-32.71%-35.71%-48.01%-63.17%-71.03%-86.83%-85.78%--13.66%LossLoss19.05%Biotechnology

News

Comments

Read more